On November 24, 2015, Woodford Investment Management, LLP announced that it sent a letter to board of Northwest Biotherapeutics, Inc. recommending that the Board establish an independent special committee to investigate certain allegations relating to the Company that have been published by at least one anonymous source and proposing that the Board appoint an additional independent non-executive director to the Board.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.432 USD | +2.86% | -6.86% | -38.37% |
05-10 | Northwest Biotherapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
03-21 | Northwest Biotherapeutics, Inc. Appoints Pat Sarma to Its Board of Directors | CI |
1st Jan change | Capi. | |
---|---|---|
-38.37% | 530M | |
+18.15% | 124B | |
+18.02% | 112B | |
+5.15% | 22.94B | |
-9.86% | 17.02B | |
-16.08% | 16.88B | |
-39.94% | 16.87B | |
+2.80% | 13.63B | |
+27.39% | 11.61B | |
+106.26% | 10.31B |
- Stock Market
- Equities
- NWBO Stock
- News Northwest Biotherapeutics, Inc.
- Woodford Investment Seeks Appointment of Independent Non Executive Member to Board of Northwest Biotherapeutics